HOME >> MEDICINE >> NEWS
Baltimore researchers receive $40 million from Bill & Melinda Gates Foundation

Johns Hopkins School of Public Health and University of Maryland School of Medicine to develop ground-breaking measles vaccine for infants in developing countries

The Bill & Melinda Gates Foundation has awarded grants of $20 million each to the University of Maryland School of Medicine and the Johns Hopkins University School of Public Health to develop a new type of measles vaccine that, for the first time, would protect infants younger than 9 months old. Such a vaccine would dramatically reduce the suffering and death rate from measles in developing countries.

"Finding a safe and effective vaccine to protect the world's youngest children against measles is an urgent global health priority," says Bill Foege, Senior Health Advisor at the Bill & Melinda Gates Foundation. "We are tremendously hopeful that this collaboration between two major research facilities will speed the development of this important vaccine and ultimately help save millions of children's lives."

Measles kills more than 900,000 children each year in less developed parts of the world, according to the World Health Organization (WHO). While widespread use of the current injected measles vaccine has saved the lives of millions of children, the disease is far from being eradicated in the developing world because a window of vulnerability exists among infants from 5 to 8 months of age.

Newborns are protected against measles by antibodies passed to them from their mothers, but those antibody levels drop steadily over time, increasing the infants' susceptibility to measles. At the same time, low levels of the mother's antibodies neutralize the effectiveness of the measles vaccine. For that reason, the WHO recommends that the current measles vaccine be administered when children are at least 9 months old.

"We are pleased that the Bill & Melinda Gates Foundation has asked us to take on this ambitious, five-year project. It will involve laboratory work as well as cl
'"/>

Contact: Dennis O'Shea
dro@jhu.edu
410-516-7109
Johns Hopkins University
27-Aug-2000


Page: 1 2 3 4

Related medicine news :

1. Impact of 2002 Canadian forest fires felt 700 miles away in Baltimore, Maryland
2. HIV infection rate and risky behavior decline amoung injection drug users in Baltimore
3. Indiana University researchers closer to helping hearing-impaired using stem cells
4. Protein that helps skin cancer spread identified by Stanford researchers
5. US life expectancy about to decline, researchers say
6. Gene for age-related macular degeneration discovered by Yale researchers
7. Dartmouth researchers find where musical memories are stored in the brain
8. Columbia researchers receive $3 million to combat genetic killer of infants & toddlers
9. US cancer researchers launch first American-Israeli cancer conference
10. USC dental researchers develop first test for predicting cavities in children
11. Young blood revives aging muscles, Stanford researchers find

Post Your Comments:
(Date:5/26/2015)... CA (PRWEB) May 27, 2015 ... beautiful technology for women, today announces the ... monitors women’s stress, sleep, activity and ovulation. The ... with innovative health tracking technolo- gy, particularly its ... levels, to provide women with lifestyle data and ...
(Date:5/26/2015)... May 27, 2015 Securityhunter ... (MATOC) by the United States Department of Health and ... The MATOC was awarded through the General ... (FSS) for the PSC, which is a fee-for-service agency. ... one year options, and is an enterprise–wide physical security ...
(Date:5/26/2015)... (PRWEB) May 27, 2015 This summer, ... connecting with local communities at key events in Greater Boston ... supplied with free copies of ChopChop Magazine, healthy snacks and ... to stay active. , “We want to get our message ... out in a memorable and fun way,” explains Sally Sampson, ...
(Date:5/26/2015)... 26, 2015 Mr. Gould and Mr. Ken ... start working together this week to ensure a smooth transition. ... healthcare executive leadership and strategy. Gary is familiar with ... hiring of Mr. Cochran. The Board of Trustees believe Mr. ... improvement strategies implemented over the past few years. , ...
(Date:5/26/2015)... May 26, 2015 The federal court ... filed on behalf of individuals who were allegedly injured ... June 11th Science Day. According to an Order issued ... on May 21st, topics to be addressed include Xarelto ... use of blood test based testing with Xarelto, and ...
Breaking Medicine News(10 mins):Health News:Bellabeat debuts the LEAF - smart jewelry that monitors women’s health. 2Health News:Bellabeat debuts the LEAF - smart jewelry that monitors women’s health. 3Health News:Securityhunter Has Been Awarded a Multiple Award Task Order Contract (MATOC) by the Department of Health and Human Services 2Health News:Award-Winning Cooking Magazine for Kids Takes Healthy Cooking and Eating to the Streets with One-of-a-Kind Bike Campaign 2Health News:Federal Xarelto Lawsuits Move Forward, as Court Establishes Procedures for Upcoming Science Day 2Health News:Federal Xarelto Lawsuits Move Forward, as Court Establishes Procedures for Upcoming Science Day 3Health News:Federal Xarelto Lawsuits Move Forward, as Court Establishes Procedures for Upcoming Science Day 4
(Date:5/26/2015)... -- OrthoAccel ® Technologies, Inc., the leader in non-invasive, accelerated ... response to continued demand from orthodontists and patients for ... practice locations in the U.S. and Canada ... is the only FDA-cleared Class II medical device that ... as much as 50 percent.  A ...
(Date:5/26/2015)... 2015 Aethlon Medical, Inc. (OTCQB: AEMD), ... address infectious diseases and cancer, today announced that ... will present at the SeeThruEquity 4th Annual Microcap ... Aethlon Medical,s presentation are as follows:Event: , SeeThruEquity ... May 28, 2015Time: , 8:00 a.m. Pacific Time ...
(Date:5/26/2015)... -- ViiV Healthcare, Aurobindo Pharma, and the ... Aurobindo Pharma has submitted an Abbreviated New Drug Application ... Food and Drug Administration (FDA), for the treatment of ... version of dolutegravir, less than two years after FDA ... the United States . Upon receiving ...
Breaking Medicine Technology:OrthoAccel Technologies Continues Trajectory of Accelerated Growth with Over 2,500 Practice Locations 2OrthoAccel Technologies Continues Trajectory of Accelerated Growth with Over 2,500 Practice Locations 3Aethlon Medical to Present at SeeThruEquity Microcap Investor Conference 2Aethlon Medical to Present at SeeThruEquity Microcap Investor Conference 3Aethlon Medical to Present at SeeThruEquity Microcap Investor Conference 4ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 2ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 3ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 4ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 5ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 6ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 7
Cached News: